Mr Peter Cheng
Mr Peter Cheng is the Chief Technology Officer of Biobot Surgical Pte Ltd and Zicom Medtacc Pte Ltd. He is also a director in Zicom Medtacc Pte Ltd, a company focusing on investments and acceleration of early stage medical technologies companies. It is also supported by SPRING Singapore. Biobot Surgical Pte Ltd is a spinoff from SingHealth and NTU that has developed a robotic platform for performing transperineal prostate biopsy. Mr. Cheng graduated with a Bachelor in Mechanical Engineering Nanyang Technological Institute and bring along more than 25 years of R&D & management experience over a broad spectrum of industries; from digital storage to domestic appliances to wind energy.